Metabolic profiling reveals reprogramming of lipid metabolic pathways in treatment of polycystic ovary syndrome with 3‐iodothyronamine

Complex diseases such as polycystic ovary syndrome (PCOS) are associated with intricate pathophysiological, hormonal, and metabolic feedbacks that make their early diagnosis challenging, thus increasing the prevalence risks for obesity, cardiovascular, and fatty liver diseases. To explore the crosst...

Descripción completa

Detalles Bibliográficos
Autores principales: Selen Alpergin, Ebru S., Bolandnazar, Zeinab, Sabatini, Martina, Rogowski, Michael, Chiellini, Grazia, Zucchi, Riccardo, Assadi‐Porter, Fariba M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5256158/
https://www.ncbi.nlm.nih.gov/pubmed/28082426
http://dx.doi.org/10.14814/phy2.13097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5256158/
https://www.ncbi.nlm.nih.gov/pubmed/28082426
http://dx.doi.org/10.14814/phy2.13097

Ejemplares similares